HOME / Notice / News / EN
Potential for Growth in the Domestic Cell Therapy Market through the Application of Negative Regulation The Ministry of SMEs and Startups announced that on the 21st, it held the "Global Innovation Zone Launch Ceremony" at the Lotte Hotel in Jung-gu, Seoul, with representatives from local governments,...
[ NKCL participates as an anchor company in the Chungbuk Advanced Regenerative Bio Global Innovation Special Zone project ] In establishing a business plan for "Designation of Chungbuk Advanced Regenerative Bio Global Innovation Special Zone" announced last December, on January 19th, hosted by the Ch...
The 2023 TV Chosun Management Awards won the Grand Prize in the Innovative Management Technology category NKCL Bio Group Inc. (Chairman: Shin Dong-hwa) won the Innovation Management Technology Award at the '10th 2023 TV Chosun Management Awards,' announced on the 2nd, marking their consecutive win fo...
KCL Bio Group Inc. Receives 'Minister of Science and Technology Award' NKCL Bio Group Inc. (led by Chairman Shin Dong-hwa) declared on the 2nd that it secured the Minister of Science and ICT Award in the technology innovation category at the '10th 2023 TV Chosun Management Awards'. NKCL Bio Group Inc...
"Chairman Shin Dong-hwa: 'Leading Technology and Market in the Field of NK Cells to Enhance National Competitiveness'" "NKCL Bio Group (NKCL Bio Group Co., Ltd.) has won the 'Minister of Food and Drug Safety Award' in the R&D Management category at the 2023 National Empathy Management Awards. (Ph...